Impact of Mesenchymal Stem Cell secreted PAI-1 on colon cancer cell migration and proliferation

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 574-579

  Hogan, Niamh M ^a   Joyce, Myles R ^b   Murphy, J Mary ^a   Barry, Frank P ^a   O'Brien, Timothy ^a   Kerin, Michael J ^a   Dwyer, Roisin M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Colorectal cancer; Mesenchymal Stem Cell; Plasminogen activator inhibitor type 1

Indexed keywords

CHEMOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR; MOLECULAR SCAFFOLD; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CHEMI ARRAY; COLON CANCER; COLON CANCER CELL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDIATOR; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; HUMANS; MESENCHYMAL STROMAL CELLS; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 84878993214     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.013     Document Type: Article

References (26)

1. O'Connell J.B., Maggard M.A., Ko C.Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J. Natl. Cancer Inst. 2004, 96:1420-1425.
2. Nakagawa H., Liyanarachchi S., Davuluri R.V., Auer H., Martin E.W., de la Chapelle A., Frankel W.L. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 2004, 23:7366-7377.
3. Gout S., Huot J. Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron. 2008, 1:69-83.
4. Mesker W.E., Junggeburt J.M., Szuhai K., de Heer P., Morreau H., Tanke H.J., Tollenaar R.A. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell. Oncol. 2007, 29:387-398.
5. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl. J. Med. 1986, 315:1650-1659.
6. Shinagawa K., Kitadai Y., Tanaka M., Sumida T., Kodama M., Higashi Y., Tanaka S., Yasui W., Chayama K. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int. J. Cancer 2010, 127:2323-2333.
7. Liu Y., Han Z.P., Zhang S.S., Jing Y.Y., Bu X.X., Wang C.Y., Sun K., Jiang G.C., Zhao X., Li R., Gao L., Zhao Q.D., Wu M.C., Wei L.X. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J. Biol. Chem. 2011, 286:25007-25015.
8. De Boeck A., Pauwels P., Hensen K., Rummens J.L., Westbroek W., Hendrix A., Maynard D., Denys H., Lambein K., Braems G., Gespach C., Bracke M., Wever O.D. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut 2013, 62:550-560.
9. Hogan N.M., Dwyer R.M., Joyce M.R., Kerin M.J. Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. Int. J. Cancer 2012, 131:1-7.
10. Alphonso A., Alahari S.K. Stromal cells and integrins: conforming to the needs of the tumor microenvironment. Neoplasia 2009, 11:1264-1271.
11. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3:791-800.
12. Conroy H., Mawhinney L., Donnelly S.C. Inflammation and cancer: macrophage migration inhibitory factor (MIF)-the potential missing link. QJM 2010, 103:831-836.
13. Mitchell R.A., Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor. Semin Cancer Biol. 2000, 10:359-366.
14. He X.X., Chen K., Yang J., Li X.Y., Gan H.Y., Liu C.Y., Coleman T.R., Al-Abed Y. Macrophage migration inhibitory factor promotes colorectal cancer. Mol. Med. 2009, 15:1-10.
15. Dano K., Behrendt N., Hoyer-Hansen G., Johnsen M., Lund L.R., Ploug M., Romer J. Plasminogen activation and cancer. Thromb. Haemost. 2005, 93:676-681.
16. Berger D.H. Plasmin/plasminogen system in colorectal cancer. World J. Surg. 2002, 26:767-771.
17. Balsara R.D., Ploplis V.A. Plasminogen activator inhibitor-1: the double-edged sword in apoptosis. Thromb. Haemost. 2008, 100:1029-1036.
18. Hwang J.H., Shim S.S., Seok O.S., Lee H.Y., Woo S.K., Kim B.H., Song H.R., Lee J.K., Park Y.K. Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow. J. Korean Med. Sci. 2009, 24:547-554.
19. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 2004, 36:568-584.
20. Martin F.T., Dwyer R.M., Kelly J., Khan S., Murphy J.M., Curran C., Miller N., Hennessy E., Dockery P., Barry F.P., O'Brien T., Kerin M.J. Potential role of mesenchymal stem cells MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res. Treat. 2010, 124:317-326.
21. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
22. Dwyer R.M., Kerin M.J. Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets?. Hum. Gene Ther. 2010, 21:1506-1512.
23. Illemann M., Hansen U., Nielsen H.J., Andreasen P.A., Hoyer-Hansen G., Lund L.R., Dano K., Nielsen B.S. Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1. Am. J. Clin. Pathol. 2004, 122:256-265.
24. Pyke C., Kristensen P., Ralfkiaer E., Eriksen J., Dano K. The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res. 1991, 51:4067-4071.
25. Oswald J., Boxberger S., Jorgensen B., Feldmann S., Ehninger G., Bornhauser M., Werner C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004, 22:377-384.
26. Baertschiger R.M., Serre-Beinier V., Morel P., Bosco D., Peyrou M., Clement S., Sgroi A., Kaelin A., Buhler L.H., Gonelle-Gispert C. Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PLoS One 2009, 4:e6657.